Puma Biotechnology has one approved drug, strong cash, and is developing alisertib with key ALISCA trial readouts in 1H 2026.

Today is shaping up negative for Vir Biotechnology, Inc. ( NASDAQ:VIR ) shareholders, with the analysts delivering ...

Quincy Bioscience exemplifies the concept that many breakthroughs in biotechnology can be inspired by discoveries made in ...

Taylor Gray has tried to control his glioblastoma – a malignant brain tumor – with surgery, radiation and chemotherapy. After struggling to improve his quality of life with the treatments, his ...

Society is fascinated with health, fitness and longevity. This obsession has spawned a multi-million pound industry centred ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Hotel rooms can be dirtier than you think but you'd guess that items that are used often, like pillows, would also be cleaned ...

Retirees now know how much their Social Security benefits will increase next year. The Social Security Administration (SSA) ...

So, what are retrons? They’re bacterial immune systems that save the bacterial herd by culling individual bacteria infected ...

The company's annualized recurring revenue run rate jumped 30% year over year in Q3 to $2 billion. Its gross payment volume ...